Where do Nurix Therapeutics, Inc.'s ratios come from?

Every ratio is computed from Nurix Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Profitability
Operating margin	-439.3%-30.4pp	-340.2%+50.4pp	-319.3%+24.0pp	-260.8%+26.7pp	-408.9%-214pp
Net margin	-411.4%-42.0pp	-314.9%+39.9pp	-292.5%+21.2pp	-234.6%+30.3pp	-369.4%-190pp
EBITDA margin	-427.3%-35.5pp	-329.8%+43.7pp	-308.4%+19.5pp	-250%+24.3pp	-391.8%-207pp
Free cash flow margin	-378.7%—	-313.7%—	-288.4%—	——	——
Returns
Return on equity	-61.4%+2.8pp	-49.6%+3.6pp	-65.4%-7.4pp	-50.7%+1.7pp	-64.2%+1.2pp
Return on assets	-47.2%-2.3pp	-39%-1.2pp	-47.3%-4.2pp	-37.6%+0.7pp	-44.9%-2.5pp
Return on invested capital	-70.2%+9.6pp	-72.2%-3.5pp	-81.8%-4.7pp	-66.2%+6.6pp	-79.8%-0.8pp
Efficiency
Asset turnover	0.1×0.0×	0.1×0.0×	0.2×0.0×	0.2×0.0×	0.1×-0.1×
Liquidity
Current ratio	6×-0.3×	7×+0.6×	5.4×+0.1×	6.8×+1.2×	6.3×+3.4×
Quick ratio	6×-0.3×	7×+0.6×	5.4×+0.1×	6.8×+1.2×	6.3×+3.4×
Cash ratio	0.8×-0.1×	2.9×+1.7×	1×-0.2×	1.1×-0.3×	0.9×+0.3×
Leverage
Debt-to-equity	0.1×+0.1×	0.1×0.0×	0.2×+0.1×	0.1×0.0×	0.1×-0.1×
Debt-to-assets	0.1×0.0×	0.1×0.0×	0.1×+0.1×	0.1×0.0×	0×0.0×
Per Share
Book value per share	$4.37-24.1%	$6.22-20.8%	$4.42-14.6%	$5.34-10.2%	$5.76+87.3%
Valuation
Market capitalization	$1.64B+40.1%	$1.79B+11.4%	$714.04M-61.1%	$744.82M-35.0%	$1.17B+52.2%
Enterprise value	$1.63B+45.1%	$1.6B+4.8%	$691.12M-60.8%	$711.59M-32.7%	$1.12B+49.9%
Price / sales	22.9×+2.1×	21.3×-8.2×	8.5×-24.0×	8.4×-10.0×	20.8×+11.3×
Price / book	3.4×+1.0×	3.3×+0.3×	1.9×-2.9×	1.7×-1.4×	2.4×-2.1×
EV / sales	22.7×+2.8×	19.1×-8.9×	8.3×-23.0×	8.1×-8.9×	19.9×+10.6×
Free cash flow yield	-16.6%—	-14.7%—	-33.8%—	——	——
Earnings yield	-18%-0.2pp	-14.8%-2.7pp	-34.3%-24.6pp	-27.8%-13.4pp	-17.8%+1.0pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Nurix Therapeutics, Inc.'s ratios come from?: Every ratio is computed from Nurix Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.